US Patent 10052315 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
Patent 10052315 was granted and assigned to Celgene on August, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 6, 2017
Date of Patent
August 21, 2018
Patent Applicant
Patent Application Number
15400791
Patent Citations Received
Patent Inventor Names
Ho-Wah Hui
0
Yu Pu
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10052315 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.